ArticleJournal of immune based therapies and vaccines2009

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Jerome S Harms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.